ERBB2 and breast carcinoma: Remarkably in the Kunming mouse model, loss of estrogen and progesterone receptors and low expression of Her2/neu and overexpression of c-Myc, cyclin D1 and VEGF were observed, which is recapitulated in a manner similar to that observed in human breast cancer with poor prognosis.